{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:03Z","timestamp":1788383643805,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["pathophysiologyjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pathophys.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T04:16:06Z","timestamp":1557375366000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: Relation to outcomes?"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-4652","authenticated-orcid":false,"given":"Oksana","family":"Sulaieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Chernenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelisaveta","family":"Chereshneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibahan","family":"Tsomartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Larin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2019.05.001_bib0005","doi-asserted-by":"crossref","unstructured":"M.B. Amin , S. Edge , F. Greene , et al. AJCC Cancer Staging Manual 8th edition Springer 2017.","DOI":"10.1007\/978-3-319-40618-3"},{"issue":"10","key":"10.1016\/j.pathophys.2019.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40618-014-0166-6","article-title":"BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency","volume":"37","author":"Alretti","year":"2014","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.pathophys.2019.05.001_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4158\/EP10123.OR","article-title":"Autoimmune thyroid disease: a risk factor for thyroid cancer","volume":"17","author":"Azizi","year":"2011","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.pathophys.2019.05.001_bib0020","author":"Bychkov"},{"key":"10.1016\/j.pathophys.2019.05.001_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-med-061512-105739","article-title":"Thyroid cancer","volume":"65","author":"Carling","year":"2014","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.pathophys.2019.05.001_bib0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2265.2012.04383.x","article-title":"Correlation of TSH with the risk of paediatric thyroid carcinoma","volume":"77","author":"Chiu","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.pathophys.2019.05.001_bib0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ando.2011.07.032","article-title":"An elevated level of TSH might be predictive of differentiated thyroid cancer","volume":"72","author":"Dorange","year":"2011","journal-title":"Ann. Endocrinol.-Paris"},{"issue":"4","key":"10.1016\/j.pathophys.2019.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.1015557108","article-title":"Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice","volume":"108","author":"Franco","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.pathophys.2019.05.001_bib0045","doi-asserted-by":"crossref","first-page":"e9619","DOI":"10.1097\/MD.0000000000009619","article-title":"Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer","volume":"97","author":"Genpeng","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"August (2)","key":"10.1016\/j.pathophys.2019.05.001_bib0050","first-page":"308","article-title":"Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?","volume":"61","author":"Giswan","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.pathophys.2019.05.001_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12020-010-9316-6","article-title":"Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?","volume":"37","author":"Gul","year":"2010","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.pathophys.2019.05.001_bib0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/thy.2016.0628","volume":"27","author":"Haugen","year":"2017","journal-title":"Thyroid."},{"issue":"3","key":"10.1016\/j.pathophys.2019.05.001_bib0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2007-2215","article-title":"Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage","volume":"93","author":"Haymart","year":"2008","journal-title":"J. Clin. Endocr. Metab."},{"issue":"8","key":"10.1016\/j.pathophys.2019.05.001_bib0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1158\/1055-9965.EPI-16-0845","article-title":"Thyroid-stimulating hormone, thyroid hormones, and risk of papillary thyroid cancer: a nested case-control study","volume":"26","author":"Huang","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.pathophys.2019.05.001_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fendo.2017.00337","article-title":"One-third of an archivial series of papillary thyroid cancer (years 2007\u20132015) has coexistent chronic lymphocytic thyroiditis, which is associated with a more favorable tumor-node-metastasis staging","volume":"8","author":"Ieni","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.pathophys.2019.05.001_bib0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/thy.2008.0061","article-title":"Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer","volume":"18","author":"Jonklaas","year":"2008","journal-title":"Thyroid"},{"issue":"1468","key":"10.1016\/j.pathophys.2019.05.001_bib0085","first-page":"69","article-title":"Rates of unsuspected thyroid cancer in multinodular thyroid disease","volume":"131","author":"Karalus","year":"2018","journal-title":"N. Z. Med. J."},{"issue":"3","key":"10.1016\/j.pathophys.2019.05.001_bib0090","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/cen.12027","article-title":"Higher TSH level is a risk factor for differentiated thyroid cancer","volume":"78","author":"Kim","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.pathophys.2019.05.001_bib0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hed.21518","article-title":"Elevated risk of papillary thyroid cancer in korean patients with Hashimoto\u2019s thyroiditis","volume":"33","author":"Kim","year":"2011","journal-title":"Head Neck-J. Sci. Spec."},{"issue":"1","key":"10.1016\/j.pathophys.2019.05.001_bib0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hed.23854","article-title":"Combined effect of Hashimoto\u2019s thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer","volume":"38","author":"Kim","year":"2016","journal-title":"Head Neck"},{"issue":"January (1)","key":"10.1016\/j.pathophys.2019.05.001_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-017-0247-6","article-title":"Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis","volume":"9","author":"Kim","year":"2018","journal-title":"J. Otolaryngol. Head Neck Surg."},{"issue":"5","key":"10.1016\/j.pathophys.2019.05.001_bib0110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/edrv.22.5.0444","article-title":"Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models","volume":"22","author":"Kimura","year":"2001","journal-title":"Endocr. Rev."},{"issue":"Junuary (1)","key":"10.1016\/j.pathophys.2019.05.001_bib0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jss.2012.08.053","article-title":"TSH increases iodine uptake by thyroid Cancer cells during BRAF silencing","volume":"182","author":"Kleiman","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.pathophys.2019.05.001_bib0120","first-page":"209","article-title":"Pathology of endocrine tumors update: world health organization new classification 2017\u2014other thyroid tumors","volume":"22","author":"Lam","year":"2017","journal-title":"AJSP: Rev. Rep."},{"key":"10.1016\/j.pathophys.2019.05.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5940367","article-title":"The association of thyrotropin and autoimmune thyroid disease in developing papillary thyroid cancer","volume":"2017","author":"Lee","year":"2017","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.pathophys.2019.05.001_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/ERC-14-0531","article-title":"BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis","volume":"22","author":"Li","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"issue":"11","key":"10.1016\/j.pathophys.2019.05.001_bib0135","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s00405-013-2872-7","article-title":"The association between BRAF (V600E) mutation and pathological features in PTC","volume":"271","author":"Liu","year":"2014","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.pathophys.2019.05.001_bib0140","series-title":"WHO Classification of Tumours of Endocrine Organs (IARC WHO Classification of Tumours)","author":"Lloyd","year":"2017"},{"issue":"7","key":"10.1016\/j.pathophys.2019.05.001_bib0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hed.21828","article-title":"Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule","volume":"34","author":"Moon","year":"2012","journal-title":"Head Neck-J. Sci. Spec."},{"issue":"8","key":"10.1016\/j.pathophys.2019.05.001_bib0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4158\/EP171805.RA","article-title":"Role of molecular markers in thyroid nodule management: then and now","volume":"23","author":"Nikiforov","year":"2017","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.pathophys.2019.05.001_bib0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CCO.0000000000000150","article-title":"Association of Hashimoto\u2019s thyroiditis and thyroid cancer","volume":"27","author":"Noureldine","year":"2015","journal-title":"Curr. Opin. Oncol."},{"issue":"7","key":"10.1016\/j.pathophys.2019.05.001_bib0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/thy.2013.0588","article-title":"Hashimoto\u2019s thyroiditis pathology and risk for thyroid cancer","volume":"24","author":"Paparodis","year":"2014","journal-title":"Thyroid"},{"issue":"April (53)","key":"10.1016\/j.pathophys.2019.05.001_bib0165","article-title":"Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients","volume":"7","author":"Resende de Paiva","year":"2017","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.pathophys.2019.05.001_bib0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3121\/cmr.2016.1309","article-title":"Biochemical testing of the thyroid: TSH is the best and, oftentimes, only test needed - a review for primary care","volume":"14","author":"Sheehan","year":"2016","journal-title":"Clin. Med. Res."},{"issue":"August (2)","key":"10.1016\/j.pathophys.2019.05.001_bib0175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12020-018-1637-x","article-title":"Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?","volume":"61","author":"Swan","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.pathophys.2019.05.001_bib0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7150\/jca.22700","article-title":"Clinical-pathological characteristics and prognostic factors for papillary thyroid microcarcinoma in the elderly","volume":"9","author":"Tang","year":"2018","journal-title":"J. Cancer"},{"issue":"February (Suppl. 1)","key":"10.1016\/j.pathophys.2019.05.001_bib0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4274\/2017.26.suppl.10","article-title":"Thyroid stimulating hormone receptor","volume":"26","author":"Tuncel","year":"2017","journal-title":"Mol. Imaging Radionucl. Ther."},{"issue":"4","key":"10.1016\/j.pathophys.2019.05.001_bib0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11154-018-9474-z","article-title":"The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma","volume":"19","author":"Vita","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"March (3)","key":"10.1016\/j.pathophys.2019.05.001_bib0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"April (Suppl. 1)","key":"10.1016\/j.pathophys.2019.05.001_bib0200","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1002\/hed.24149","article-title":"Potential relationship between Hashimoto\u2019s thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer","volume":"38","author":"Zeng","year":"2016","journal-title":"Head Neck"}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468018303146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468018303146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T17:15:44Z","timestamp":1663434944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468018303146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0928468018303146"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2019.05.001","relation":{},"ISSN":["0928-4680"],"issn-type":[{"value":"0928-4680","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: Relation to outcomes?","name":"articletitle","label":"Article Title"},{"value":"Pathophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathophys.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}